<?xml version="1.0" encoding="iso-8859-1"?> 
<rss version="2.0" xmlns:creativeCommons="http://backend.userland.com/creativeCommonsRssModule" 
xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" 
xmlns:atom="http://www.w3.org/2005/Atom"
>
<channel>
<title>International Journal of Medical Sciences</title> 
<link>http://www.medsci.org</link> 
<description>International Journal of Medical Sciences RSS feed -- Volume 9</description> 
<language>en-us</language> 
<pubDate>Tue, 24 Jan 2012 04:00:00 GMT</pubDate>
<lastBuildDate>Tue, 24 Jan 2012 04:00:00 GMT</lastBuildDate> 

<item>
<link>http://www.medsci.org/v09p0163.htm</link> 
<title>Cancer Survivors in the United States: A Review of the Literature and a Call to Action</title> 
<guid isPermaLink="true">http://www.medsci.org/v09p0163.htm</guid> 
<description><![CDATA[ <p><b>Background: </b>The number of cancer survivors in the U.S. has increased from 3 million in 1971, when the National Cancer Act was enacted, to over 12 million today. Over 70% of children affected by cancer survive more than 10 years, and most are cured. Most cancer survivors are adults, with two-thirds of them 65 years of age or older and two-thirds alive at five years. The most common cancer diagnoses among survivors include breast, prostate and colorectal cancers. This review was conducted to better appreciate the challenges associated with cancer survivors and the opportunities healthcare providers have in making a difference for these patients.</p><p><b>Methods: </b>Comprehensive review of literature based on PubMed searches on topics related to cancer survivorship, and associated physical, cognitive, socio-economic, sexual/behavioral and legal issues.</p><p><b>Results: </b>At least 50% of cancer survivors suffer from late treatment-related side effects, often including physical, psychosocial, cognitive and sexual abnormalities, as well as concerns regarding recurrence and/or the development of new malignancies. Many are chronic in nature and some are severe and even life-threatening. Survivors also face issues involving lack of appropriate health maintenance counseling, increased unemployment rate and workplace discrimination.</p><p><b>Conclusions: </b>Advances in the diagnosis and treatment of cancer will lead to more survivors and better quality of life. However, tools to recognize potentially serious long-lasting side effects of cancer therapy earlier in order to treat and/or prevent them must be developed. It is incumbent upon our health care delivery systems to make meeting these patients' needs a priority.</p> ]]></description>  
<dc:creator>Manuel Valdivieso, Ann M. Kujawa, Tisha Jones, Laurence H. Baker</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>9</prism:volume> 
  <prism:number>2</prism:number> 
  <prism:startingPage>163</prism:startingPage> 
  <prism:endingPage>173</prism:endingPage> 
  <prism:publicationDate>2012-1-17</prism:publicationDate> 
<prism:section>Review</prism:section>
</item>

<item>
<link>http://www.medsci.org/v09p0157.htm</link> 
<title>Inhaled Nitric Oxide Therapy Fails to Improve Outcome in Experimental Severe Influenza</title> 
<guid isPermaLink="true">http://www.medsci.org/v09p0157.htm</guid> 
<description><![CDATA[ <p><i>In vitro</i>, nitric oxide (NO) has been shown to have antimicrobial activity against a wide range of viruses, including influenza A virus. Therefore, we hypothesized that inhaled nitric oxide (iNO) would increase survival <i>in vivo</i> by reducing the viral load in C57Bl/6 mice infected with a lethal dose of influenza A/WSN/33 (H1N1; WSN/33) virus. NO was delivered to influenza-infected mice either continuously or intermittently at 80 or 160 ppm, respectively, using both prophylactic and post-infection treatment strategies. Murine survival and weight loss were assessed, and lung viral load was quantified via plaque assay. Here, we report that iNO administered prophylactically or post-influenza infection failed to improve survival of infected mice. No difference in lung viral load was observed between experimental groups. Although NO has antiviral activity against influenza A virus <i>in vitro</i>, iNO therapy provided no apparent benefit when used for treatment of influenza A virus infection <i>in vivo</i>.</p> ]]></description>  
<dc:creator>Ilyse Darwish, Chris Miller, Kevin C. Kain, W. Conrad Liles</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>9</prism:volume> 
  <prism:number>2</prism:number> 
  <prism:startingPage>157</prism:startingPage> 
  <prism:endingPage>162</prism:endingPage> 
  <prism:publicationDate>2012-1-13</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.medsci.org/v09p0148.htm</link> 
<title>Rapid Detection of rpoB Mutations in Rifampin Resistant M. tuberculosis from Sputum Samples by Denaturing Gradient Gel Electrophoresis</title> 
<guid isPermaLink="true">http://www.medsci.org/v09p0148.htm</guid> 
<description><![CDATA[ <p><b>Objective</b>: To establish a rapid detection method for identifying <i>rpoB</i> mutations associated with rifampin (RIF) resistance in sputum specimens.</p><p><b>Methods</b>: We detected <i>rpoB</i> mutations directly in 90 sputum specimens collected from suspected tuberculosis patients using PCR-based denaturing gradient gel electrophoresis (DGGE) and compared these results with those obtained by <i>rpoB</i> sequencing and conventional drug susceptibility testing.</p><p><b>Results</b>: The positive detection rate of <i>Mycobacterium tuberculosis</i> (<i>M. tuberculosis</i>) was 52.2% by Acid-Fast Bacilli staining and 72.2% by conventional <i>mycobacterial</i> culture. In contrast, the positive rate was significantly higher (93.3%) by PCR-based detection of the <i>rpoB</i> gene in the same specimens. Furthermore, 75% of the tested specimens presented abnormal patterns compared with the wild-type pattern (standard H37Rv strain) analysed by DGGE. A total of 12 different patterns, representing 12 different <i>rpoB</i> mutations, were observed in the 63 abnormal patterns. The match rate of <i>rpoB</i> mutations detected by DGGE reached 96.9% when compared to DNA sequencing.</p><p><b>Conclusion</b>: Our findings indicate that PCR-based DGGE is a rapid and reliable bio-technique for direct detection of <i>rpoB</i> mutations associated with RIF resistance in the sputum of suspected tuberculosis patients.</p> ]]></description>  
<dc:creator>Jun Li, Jiaojiao Xin, Liyuan Zhang, Longyan Jiang, Hongcui Cao, Lanjuan Li</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>9</prism:volume> 
  <prism:number>2</prism:number> 
  <prism:startingPage>148</prism:startingPage> 
  <prism:endingPage>156</prism:endingPage> 
  <prism:publicationDate>2012-1-11</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.medsci.org/v09p0142.htm</link> 
<title>What Questions do People Ask on a Human Papillomavirus Website? A Comparative Analysis of Public and Private Questions</title> 
<guid isPermaLink="true">http://www.medsci.org/v09p0142.htm</guid> 
<description><![CDATA[ <p>Objective: In 2004, we launched the question and answer (Q&#38;A) section on a human papillomavirus (HPV) website (<ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.hpvkorea.org">www.hpvkorea.org</ext-link>) that provides ample and regularly updated information about HPV. The purpose of this study is to collect data pertaining to questions posed on this website about HPV and its related diseases and analyze the type of questions and frequency before and after introduction of HPV vaccine in Korea. Using these results, we intend to determine the clinical and practical implications for doctors treating HPV and for HPV website providers.</p><p>Method: Data were collected from March 2004 to July 2011. This study analyzed all the questions that were asked on the website during this period. The questions were categorized into 2 groups, according to whether they were asked publicly or privately. The 10 categories for classification were determined on the basis of the contents of the questions by 4 researchers with medical degrees (Ph.D.) related to HPV research. The frequency of the questions was separately determined for the public and private question formats. Also, we compared the type of questions and frequency before and after introduction of HPV vaccine in Korea and evaluated the changes in the 2 groups over the 2 periods studied.</p><p>Results: Of the 3,062 subjects who visited the HPV website, 2,330 subjects asked public questions and 732 asked private questions. The most frequent question was &#8220;I have been infected with HPV, and I want to know about the treatment options for HPV infection and cervical dysplasia&#8221; (n = 1156, 37.8%), and the second most common question was &#8220;What are the transmission routes of HPV?&#8221; (n = 684, 22.3%). The third most common question was &#8220;How long does it take for HPV infection to spontaneously remit?&#8221; (n = 481, 15.7%).</p><p>Of the 2,330 public questions, the most common question types pertained to the treatment of HPV and cervical dysplasia, HPV transmission, HPV remission, and risk of cervical cancer (in that order). Of the 732 private questions, the most frequent question types pertained to the HPV transmission, treatment of HPV and cervical dysplasia, genital warts, and HPV &#38; pregnancy (in that order). The type and frequency of public and private questions showed statistical differences between the 2 groups (p &#60; 0.001).</p><p>Conclusion: Our results show that when people consult an internet site about HPV, they actually want to seek about &#8220;treatment of HPV and cervical dysplasia&#8221;, &#8220;HPV transmission&#8221;, &#8220;HPV remission&#8221;, &#8220;genital warts&#8221;, and &#8220;risk of cervical cancer&#8221; (in this order). Also, our results showed that &#8220;genital warts&#8221; and &#8220;HPV &#38; pregnancy&#8221; may have been considered embarrassing topics. Thus, these findings can be used to make informed recommendations for future clinical or internet-based communications with patients and the general public.</p> ]]></description>  
<dc:creator>Sung-Jong Lee, Hae-Jung Yun, Keun-Ho Lee, Chan-Joo Kim, Jong-Sup Park</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>9</prism:volume> 
  <prism:number>2</prism:number> 
  <prism:startingPage>142</prism:startingPage> 
  <prism:endingPage>147</prism:endingPage> 
  <prism:publicationDate>2012-1-10</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.medsci.org/v09p0137.htm</link> 
<title>Oral and Maxillofacial Considerations in Gardner's Syndrome</title> 
<guid isPermaLink="true">http://www.medsci.org/v09p0137.htm</guid> 
<description><![CDATA[ <p>Gardner's Syndrome is a variant of familial adenomatosis polyposis (FAP) with a triad consisting of polyps of the colon, multiple osteomas and surface tumors of soft and hard tissue. The intestinal polyps have a %100 risk of undergoing malignant transformation, therefore early identification of this disease is very important. There are several symptoms of Gardner's syndrome in the oral and maxillofacial surgery, which can be discovered during routine dental examination. We report a case of a 25-year old male patient with Gardner's syndrome who has not any intestinal polyps but osteomas in the mandible and jaw deformalities.</p> ]]></description>  
<dc:creator>Abdulkadir Burak Cankaya, Mehmet Ali Erdem, Sabri Cemil Isler, Muhsin Cifter, Vakur Olgac, Cetin Kasapoglu, Cuneyt Korhan Oral</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>9</prism:volume> 
  <prism:number>2</prism:number> 
  <prism:startingPage>137</prism:startingPage> 
  <prism:endingPage>141</prism:endingPage> 
  <prism:publicationDate>2012-1-7</prism:publicationDate> 
<prism:section>Case Report</prism:section>
</item>

<item>
<link>http://www.medsci.org/v09p0129.htm</link> 
<title>Effects of Two Fluoride Varnishes and One Fluoride/Chlorhexidine Varnish on Streptococcus mutans and Streptococcus sobrinus Biofilm Formation in Vitro</title> 
<guid isPermaLink="true">http://www.medsci.org/v09p0129.htm</guid> 
<description><![CDATA[ <p><b>Aims</b>: The aim of this study was to evaluate and to compare the effect of two fluoride varnishes and one fluoride/chlorhexidine varnish on <i>Streptococcus mutans</i> and <i>Streptococcus sobrinus</i> biofilm formation, in vitro.</p><p><b>Study design</b>: Standard acrylic discs were prepared and divided into groups based on the varnish applied to the disc surface: Fluor Protector, Bifluoride 12, and Fluor Protector + Cervitec (1:1). Untreated discs served as controls. In the study groups, biofilms of <i>S. mutans</i> and <i>S. sobrinus </i>were formed over 24 h, 48 h, and 5 days. The fluoride concentrations in the monospecies biofilms and viable counts of<i> S. mutans</i> and <i>S. sobrinus </i>were investigated.</p><p><b>Results</b>: In all study groups, a statistically significant increase in the viable number of <i>S. mutans</i> and <i>S. sobrinus</i> cells was observed between 24 h and 5 days. In both monospecies biofilms, the greatest antibacterial efficacy was detected in the Fluor Protector and Fluor Protector + Cervitec groups at 24 h. For all groups, the amount of fluoride released was highest during the first 24 h, followed by a significant decrease over the next 4 days. A negative correlation was detected between fluoride concentration and antibacterial effect in those groups with biofilms containing both species. Despite the release of high levels of fluoride, the greatest number of viable <i>S. mutans</i> and <i>S. sobrinus </i>cells was detected in the Bifluoride 12 group.</p><p><b>Statistics</b>: The data were analyzed using GraphPad Prism software (ver. 3).</p><p><b>Conclusions</b>: The Fluor Protector + Cervitec varnish exerted prolonged antibacterial effects on <i>S. mutans</i> and <i>S. sobrinus </i>biofilms compared to the other varnishes tested.</p> ]]></description>  
<dc:creator>Arzu Pinar Erdem, Elif Sepet, G&#252;ven Kulekci, Sule Can Trosola, Yegane Guven</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>9</prism:volume> 
  <prism:number>2</prism:number> 
  <prism:startingPage>129</prism:startingPage> 
  <prism:endingPage>136</prism:endingPage> 
  <prism:publicationDate>2012-1-7</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.medsci.org/v09p0126.htm</link> 
<title>Potential Impact of the Financial Crisis on Outpatient Hospital Visits due to Otorhinolaryngologic Disorders in Crete, Greece</title> 
<guid isPermaLink="true">http://www.medsci.org/v09p0126.htm</guid> 
<description><![CDATA[ <p>The public health effect of financial crises has been emphasized in previous studies. In addition, a series of otorhinolaryngologic disorders and manifestations has been related to psychological factors in the literature. Such conditions include temporomandibular joint disorders, laryngopharyngeal reflux, chronic tinnitus, and vertigo. Focusing on the outpatient database records of a large hospital in Crete, Greece, the objective of this retrospective study was to explore possible occurrence variations within the prementioned otorhinolaryngologic morbidity which may be potentially attributed to increased levels of socioeconomic stress. Results revealed that although the total number of visits between two periods - before and after the beginning of the financial crisis in Greece - was comparable, a significant increase in the diagnosis of two disorders, namely vertigo and tinnitus was found. In addition, a trend toward increased rate of diagnosis for reflux and temporomandibular joint disorders was noted. Potential implications of these findings are discussed. In conclusion, health care providers in this as well as in other countries facing similar socio-economic conditions should be aware of potential changes in the epidemiologic figures regarding specific medical conditions.</p> ]]></description>  
<dc:creator>Alexander D. Karatzanis, Emmanouil K. Symvoulakis, Vasilios Nikolaou, George A. Velegrakis</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>9</prism:volume> 
  <prism:number>2</prism:number> 
  <prism:startingPage>126</prism:startingPage> 
  <prism:endingPage>128</prism:endingPage> 
  <prism:publicationDate>2012-1-6</prism:publicationDate> 
<prism:section>Short Research Communication</prism:section>
</item>

<item>
<link>http://www.medsci.org/v09p0121.htm</link> 
<title>Relationship between Antithyroid Antibody and Pregnancy Outcome following in Vitro Fertilization and Embryo Transfer</title> 
<guid isPermaLink="true">http://www.medsci.org/v09p0121.htm</guid> 
<description><![CDATA[ <p><b>Objective:</b> To investigate the impact of antithyroid antibody on pregnancy outcome following the in vitro fertilization and embryo transfer (IVF-ET).</p><p><b>Methods:</b> A total of 90 patients (156 cycles) positive for antithyroid antibody (ATA+ group) and 676 infertile women (1062 cycles) negative for antithyroid antibody (ATA- group) undergoing IVF/ICSI from August 2009 to August 2010 were retrospectively analyzed.</p><p><b>Results:</b> There was no significant difference in the days of ovarian stimulation, total gonadotropin dose, serum E2 level of HCG day and number of oocytes retrieved between the two groups. The fertilization rate, implantation rate and pregnancy rate following IVF-ET were significantly lower in women with antithyroid antibody than in control group (64.3% vs 74.6%, 17.8% vs 27.1% and 33.3% vs 46.7%, respectively), but the abortion rate was significantly higher in patients with antithyroid antibody (26.9% vs 11.8%).</p><p><b>Conclusion: </b>Patients with antithyroid antibody showed significantly lower fertilization rate, implantation rate and pregnancy rate and higher risk for abortion following IVF-ET when compared with those without antithyroid antibody. Thus, the presence of antithyroid antibody is detrimental for the pregnancy outcome following IVF-ET.</p> ]]></description>  
<dc:creator>Yi-ping Zhong, Ying Ying, Hai-tao Wu, Can-quan Zhou, Yan-wen Xu, Qiong Wang, Jie Li, Xiao-ting Shen, Jin Li</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>9</prism:volume> 
  <prism:number>2</prism:number> 
  <prism:startingPage>121</prism:startingPage> 
  <prism:endingPage>125</prism:endingPage> 
  <prism:publicationDate>2012-1-5</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.medsci.org/v09p0115.htm</link> 
<title>Relationship of Visual Cortex Function and Visual Acuity in Anisometropic Amblyopic Children</title> 
<guid isPermaLink="true">http://www.medsci.org/v09p0115.htm</guid> 
<description><![CDATA[ <p><b>Purpose: </b>To detect the functional deficit of the visual cortex in anisometropic amblyopia children using functional magnetic resonance imaging (fMRI) technique, and investigate the relationship between visual acuity and visual cortex function.</p><p><b>Methods</b>: Blood oxygenation level-dependent fMRI (BOLD-fMRI) was performed in ten monocular anisometropic amblyopia children and ten normal controls. fMRI images were acquired in two runs with visual stimulation delivered separately through the sound and amblyopic eyes. Measurements were performed in cortical activation of striate and extrastriate areas at the occipital lobe. The relationship between cortex function and visual acuity was analyzed by Pearson partial analysis.</p><p><b>Results: </b>The activation areas of both the striate and extrastriate cortices in the amblyopic eyes were significantly lower than that of the sound fellow eyes. No relationship was found between the striate and extrastriate cortex activation. No relationship was found between the visual cortical activation of striate, extrastriate areas and visual acuity of anisometropic amblyopes.</p><p><b>Conclusions</b>: BOLD-fMRI revealed the independent striate and extrastriate cortical deficits in anisometropic amblyopes. In addition, the visual acuity lesion and the striate and extrastriate cortical deficits were not parallel, and results of fMRI examination have much potential value in the evaluation of amblyopia.</p> ]]></description>  
<dc:creator>Chuanming Li, Lin Cheng, Qiongwu Yu, Bing Xie, Jian Wang</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>9</prism:volume> 
  <prism:number>1</prism:number> 
  <prism:startingPage>115</prism:startingPage> 
  <prism:endingPage>120</prism:endingPage> 
  <prism:publicationDate>2011-12-17</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.medsci.org/v09p0108.htm</link> 
<title>P-wave Dispersion for Predicting Paroxysmal Atrial Fibrillation in Acute Ischemic Stroke</title> 
<guid isPermaLink="true">http://www.medsci.org/v09p0108.htm</guid> 
<description><![CDATA[ <p><b>Background:</b> Detection of paroxysmal atrial fibrillation (PAF) in acute ischemic stroke patients poses diagnostic challenge. The aim of this study was to predict the presence of PAF by means of 12-lead ECG in patients with acute ischemic stroke. Our hypothesis was that P-wave dispersion (P<sub>d</sub>) might be a useful marker in predicting PAF in patients with acute ischemic stroke.</p><p><b>Methods:</b> 12-lead resting ECGs, 24-hour Holter recordings and echocardiograms of 400 patients were analyzed retrospectively. PAF was detected in 40 patients on 24-hour Holter monitoring. Forty out of 360 age and gender matched patients without PAF were randomly chosen and assigned as the control group. Demographics, P-wave characteristics and echocardiographic findings of the patients with and without PAF were compared.</p><p><b>Results:</b> Maximum P-wave duration (p=0.002), P<sub>d</sub> (p&#60;0.001) and left atrium diameter (p=0.04) were significantly higher in patients with PAF when compared to patients without PAF. However, in binary logistic regression analysis P<sub>d</sub> was the only independent predictor of PAF. The cut-off value of P<sub>d</sub> for the detection of PAF was 57.5 milliseconds (msc). Area under the curve was 0.80 (p&#60;0.001). On a single 12-lead ECG, a value higher than 57.5 msc predicted the presence of PAF with a sensitivity of 80% and a specificity of 73%.</p><p><b>Conclusion:</b> P<sub>d</sub> on a single 12-lead ECG obtained within 24 hours of an acute ischemic stroke might help to predict PAF and reduce the risk of recurrent strokes.</p> ]]></description>  
<dc:creator>Umuttan Dogan, Ebru Apaydin Dogan, Mehmet Tekinalp, Osman Serhat Tokgoz, Alpay Aribas, Hakan Akilli, Kurtulus Ozdemir, Hasan Gok, Betigul Yuruten</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>9</prism:volume> 
  <prism:number>1</prism:number> 
  <prism:startingPage>108</prism:startingPage> 
  <prism:endingPage>114</prism:endingPage> 
  <prism:publicationDate>2011-12-17</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.medsci.org/v09p0103.htm</link> 
<title>High-risk Human Papillomavirus Infection in Low Risk Women: Incidence, Patient Characteristics, and Clinical Meaning for Cervical Cancer</title> 
<guid isPermaLink="true">http://www.medsci.org/v09p0103.htm</guid> 
<description><![CDATA[ <p><b>Objective</b>: To investigate the incidence of high-risk human papillomavirus (HPV) infection and its clinical meaning.</p><p><b>Methods</b>: Total 28,339 women attending our hospital for routine gynecologic care underwent Papanicolaou test (PAP test) and high-risk HPV tests. Biopsies were taken from some women and their results were compared.</p><p><b>Results</b>: The prevalence of high-risk HPV infection is 24.15%. And the women aged 20-29 years had the highest prevalence (32.3%) compared to 30-70 years (P&#60;0.05). Of the 28,339 women, 1369 (4.83%) had positive PAP test (ASCUS, LSIL, HSIL). Of the 1369 PAP-positive patients, only 16 (1.17%) were negative for HPV test. Of the 1353 patients positive on both tests, 510 (37.7%) had lesions higher than CINII on histology. Of the 1,611 patients who underwent biopsies, 350 underwent the loop electrical excision procedure, with 339 (96%) being positive for HPV test, including 16 with CINI, 48 with CINII/III, 74 with CIS, and 16 with cervical cancer. HPV test had a positive predictive value of 40.7% and a negative predictive value of 100% for higher than CINII.</p><p><b>Conclusion:</b> Although HPV test has a burden of cost, considering its high negative predictive value, HPV test should be considered for more useful screening test.</p> ]]></description>  
<dc:creator>Sung Jong Lee, Seung Geun Yeo, Dong Choon Park</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>9</prism:volume> 
  <prism:number>1</prism:number> 
  <prism:startingPage>103</prism:startingPage> 
  <prism:endingPage>107</prism:endingPage> 
  <prism:publicationDate>2011-12-15</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.medsci.org/v09p0093.htm</link> 
<title>Electrocardiographic Findings in Patients with Polycythemia Vera</title> 
<guid isPermaLink="true">http://www.medsci.org/v09p0093.htm</guid> 
<description><![CDATA[ <p><i>Background: </i>The 12-lead surface electrocardiogram (ECG) is a useful tool to predict both atrial and ventricular arrhythmias via P-wave and QT measurements and its derivatives. Polycythemia vera (PV) is a chronic myeloproliferative disorder associated with cardiovascular events. The aim of this study was to assess ECG findings of patients with PV.</p><p><i>Method and materials: </i>Sixty patients with PV (34 male, mean age 58&#177;11 years) and 60 age and gender-matched healthy volunteers were enrolled into the study. From the 12-lead surface ECG, P-wave and both conventional QT measurements and transmyocardial repolarization parameters (T<sub>peak</sub>-T<sub>end</sub> interval (T<sub>p</sub>-T<sub>e</sub>) and derivatives) were evaluated digitally by two experienced cardiologists. In addition, a novel parameter, Pi was calculated digitally as the standard deviation of the P-wave duration across the 12 ECG leads.</p><p><i>Results: </i>QT duration and corrected QT interval were significantly longer in the PV group compared to healthy controls (p&#60;0.01 and p&#60;0.01, respectively). The T<sub>p</sub>-T<sub>e</sub> was longer and the T<sub>p</sub>-T<sub>e</sub>/QT ratio was significantly higher in the PV group compared to the controls. P-wave analyses showed that all P-wave parameters including Pmax, Pmin, P dispersion, and Pi were significantly prolonged in PV patients compared to the controls. The increase of both T<sub>p</sub>-T<sub>e </sub>and P max in the PV group was independent of age, BMI, diabetes and hypertension, gender, systolic blood pressure, hemoglobin, hematocrit, left atrial dimension, left ventricular end-diastolic diameter and early deceleration time in a univariate analysis of co-variance model (F=11.097, p=0.001 and F=31.537, p=0.0001, respectively).</p><p><i>Conclusion: </i>The present study demonstrated that PV may be associated with electrocardiographic abnormalities of both atrium and ventricle.</p> ]]></description>  
<dc:creator>Mehmet Kayrak, Kadir Acar, Enes Elvin Gul, Turyan Abdulhalikov, Murat Ba&#287;l&#305;cakl&#305;o&#287;lu, Osman Sonmez, Zeynettin Kaya, Hatem Ar&#305;</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>9</prism:volume> 
  <prism:number>1</prism:number> 
  <prism:startingPage>93</prism:startingPage> 
  <prism:endingPage>102</prism:endingPage> 
  <prism:publicationDate>2011-12-14</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.medsci.org/v09p0086.htm</link> 
<title>Effects of Female Sex Hormones on Clusterin Expression and Paclitaxel Resistance in Endometrial Cancer Cell Lines</title> 
<guid isPermaLink="true">http://www.medsci.org/v09p0086.htm</guid> 
<description><![CDATA[ <p>Objective: We have analyzed the association between clusterin expression in endometrial cancer cells and their resistance to paclitaxel. We also analyzed whether the effects of female sex hormones on clusterin expression by these cell lines affect their resistance to paclitaxel. Methods: The expression of estrogen receptors &#945; and &#946;, progesterone receptors AB and B, and clusterin mRNA and protein was assayed in the ECC-1 and KLE endometrial cancer cell lines by RT-PCR and Western blotting, respectively. The IC<sub>50</sub> of paclitaxel was measured in each cell line by XTT assay. Using clusterin siRNA, we analyzed the association between clusterin expression and paclitaxel IC<sub>50</sub> in each cell line. We also examined the effects of hormone treatment on cellular resistance to paclitaxel. Results: Paclitaxel IC<sub>50</sub> was significantly higher in KLE cells, which expressed higher levels of clusterin, than in ECC-1 cells, which expressed lower levels of clusterin. Conversely, incubation with clusterin siRNA significantly decreased the viability of KLE cells (P&#60;0.001), but did not alter the viability of ECC-1 cells. Incubation with estrogen tended to increase the level of clusterin expression in these endometrial cancer cell lines, although the level of clusterin expression did not correlate with that of estrogen receptors. Incubation with progesterone did not alter the levels of expression of clusterin and clusterin receptor. Incubation with estrogen and paclitaxel significantly increased the viability of ECC-1 (P&#60;0.001) but not KLE cells. Conclusion: Estrogen increases the paclitaxel resistance of endometrial cancer cell lines, by increasing clusterin expression.</p> ]]></description>  
<dc:creator>Yong Sung Won, Sung Jong Lee, Seung Geun Yeo, Dong Choon Park</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>9</prism:volume> 
  <prism:number>1</prism:number> 
  <prism:startingPage>86</prism:startingPage> 
  <prism:endingPage>92</prism:endingPage> 
  <prism:publicationDate>2011-12-11</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.medsci.org/v09p0083.htm</link> 
<title>Tender Papule Rising on the Digit: Pacinian Neuroma Should Be Considered in Differential Diagnosis</title> 
<guid isPermaLink="true">http://www.medsci.org/v09p0083.htm</guid> 
<description><![CDATA[ <p>Pacinian corpuscles are sensory nerve-end organs located in the deep dermis and subcutaneous tissue of the palms or soles. Pacinian neuroma is an extremely rare feature, defined as hyperplasia or hypertrophy of Pacinian corpuscles. About half of Pacinian neuromas present with point tenderness. There have been a limited number of cases reported around the world.</p><p>We observed a 45-year-old woman with an 8-month history of a tender whitish papule on her left thumb tip. Histopathologically, an enlarged hypertrophic Pacinian corpuscle in subcutaneous tissue, surrounded by numerous nerve fibers, was found. Herein, we report a case of Pacinian neuroma presenting as a tender papule on a fingertip that was clearly related to repetitive trauma at that site. This case shows that a meticulous history and histological examination can lead to an exact diagnosis and proper treatment.</p> ]]></description>  
<dc:creator>Hyun Hee Cho, Jong Soo Hong, Se Young Park, Hyun Sun Park, Soyun Cho, Jong Hee Lee</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>9</prism:volume> 
  <prism:number>1</prism:number> 
  <prism:startingPage>83</prism:startingPage> 
  <prism:endingPage>85</prism:endingPage> 
  <prism:publicationDate>2011-12-6</prism:publicationDate> 
<prism:section>Case Report</prism:section>
</item>

<item>
<link>http://www.medsci.org/v09p0074.htm</link> 
<title>Early Biventricular Molecular Responses to an Acute Myocardial Infarction</title> 
<guid isPermaLink="true">http://www.medsci.org/v09p0074.htm</guid> 
<description><![CDATA[ <p><b>Background: </b>Acute myocardial infarction (AMI) remains as one of the most common lethal diseases in the world and therefore it is necessary to understand its effect on molecular basis. Genome-wide microarray analysis provides us to predict potential biomarkers and signaling pathways for this purpose.</p><p><b>Objectives: </b>The aim of this study is to understand the molecular basis of the immediate right ventricular cellular response to left ventricular AMI.</p><p><b>Material and Methods:</b> A rat model of left anterior descending coronary artery ligation was used to assess the effect of left ventricular AMI on both the right ventricle as a remote zone and the left ventricle as an ischemic/infarct zone. Microarray technology was applied to detect the gene expression. Gene Ontology and KEGG pathways analysis were done to identify effected pathways and related genes.</p><p><b>Results: </b>We found that immune response, cell chemotaxis, inflammation, cytoskeleton organization are significantly deregulated in ischemic zone as early response within 30 min. Unexpectedly, there were several affected signaling pathways such as cell chemotaxis, regulation of endothelial cell proliferation, and regulation of caveolea regulation of anti-apoptosis, regulation of cytoskeleton organization and cell adhesion on the remote zone in the right ventricle.</p><p><b>Conclusion: </b>This data demonstrates that there is an immediate molecular response in both ventricles after an AMI. Although the ischemia did not histologically involve the right ventricle; there is a clear molecular response to the infarct in the left ventricle. This provides us new insights to understand molecular mechanisms behind AMI and to find more effective drug targets.</p> ]]></description>  
<dc:creator>Cenk Erdal, G&#246;khan Karak&#252;lah, Emel Fermanc&#305;, &#304;mge Kunter, Erdem Silistreli, T&#252;lay Canda, Esra Erdal, Hasan Hepaguslar</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>9</prism:volume> 
  <prism:number>1</prism:number> 
  <prism:startingPage>74</prism:startingPage> 
  <prism:endingPage>82</prism:endingPage> 
  <prism:publicationDate>2012--</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.medsci.org/v09p0068.htm</link> 
<title>Clinicopathological Characteristics and Prognosis of Non-Small Cell Lung Cancer Patients Associated with a Family History of Lung Cancer</title> 
<guid isPermaLink="true">http://www.medsci.org/v09p0068.htm</guid> 
<description><![CDATA[ <p><b>Introduction: </b>Clinicopathological characteristics and prognosis of non-small cell lung cancer (NSCLC) patients with a family history of lung cancer (FHLC) have not been well established.</p><p><b>Methods</b>: Clinical records of patients with NSCLC treated at our institute from 1982 to 2010 were reviewed with special reference to family history of lung cancer and clinicopathological factors including patient's outcome. Univariate analyses of the factors between the groups of FHLC and non-FHLC were performed using unpaired two-tailed t tests or the chi-square test. The Cox proportional hazards model was used to evaluate the hazard ratio of death.</p><p><b>Results: </b>Of the 1013 NSCLC patients, 124 (12.2%) had a FHLC of whom 119 (96%) were the first-degree relatives. The frequency of early stages of lung cancer was high in both groups of FHLC and non-FHLC patients. Patients with FHLC had a significantly higher frequency of early pathological stages and a prepomderance of adenocarcinoma, and a hazard ratio of death of 0.870 (95% confidence interval: 0.599-1.263, p value: 0.465) compared with the non-FHLC patients.</p><p><b>Conclusions</b>: NSCLC patients with FHLC could be characterized by early pathological stages and preponderance of adenocarcinoma, however they were not at a decreased hazard ratio of death. These findings emphasize the importance of early detection of lung cancer and employment of less invasive therapeutic interventions.</p> ]]></description>  
<dc:creator>Shuji Haraguchi, Kiyoshi Koizumi, Iwao Mikami, Okamoto Junichi, Yoshihito Iijima, Takayuki Ibi, Kazuo Shimizu</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>9</prism:volume> 
  <prism:number>1</prism:number> 
  <prism:startingPage>68</prism:startingPage> 
  <prism:endingPage>73</prism:endingPage> 
  <prism:publicationDate>2011-11-30</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.medsci.org/v09p0065.htm</link> 
<title>Delayed Intracerebral Hemorrhage Secondary to Ventriculoperitoneal Shunt: Two Case Reports and a Literature Review</title> 
<guid isPermaLink="true">http://www.medsci.org/v09p0065.htm</guid> 
<description><![CDATA[ <p>Ventriculoperitoneal (VP) shunt has become a popular operation to achieve cerebrospinal fluid (CSF) diversion, but is associated with many complications. Postoperative delayed intracerebral hemorrhage is a kind of rare but severe event, which has not thus far been reported in retrospective case analyses. Here we present two cases of delayed intracerebral hemorrhage, along the path of the ventricular catheter, which occurred on postoperative days 3 and 5. We also provide a literature review regarding this rare complication.</p> ]]></description>  
<dc:creator>Feng Zhou, Qichang Liu, Guangyu Ying, Xiangdong Zhu</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>9</prism:volume> 
  <prism:number>1</prism:number> 
  <prism:startingPage>65</prism:startingPage> 
  <prism:endingPage>67</prism:endingPage> 
  <prism:publicationDate>2011-11-24</prism:publicationDate> 
<prism:section>Case Report</prism:section>
</item>

<item>
<link>http://www.medsci.org/v09p0059.htm</link> 
<title>A Randomized Clinical Trial Comparing the Effect of Rapidly Infused Crystalloids on Acid-Base Status in Dehydrated Patients in the Emergency Department</title> 
<guid isPermaLink="true">http://www.medsci.org/v09p0059.htm</guid> 
<description><![CDATA[ <p>Study objective: To compare the effect of normal saline (NS), lactated Ringer's, and Plasmalyte on the acid-base status of dehydrated patients in the emergency department (ED).</p><p>Method: We conducted a prospective, double-blind, randomized trial of consecutive adult patients who presented to the emergency department with moderate-severe dehydration. Patients were randomly allocated to blindly receive normal saline (NS), lactated Ringer's or Plasmalyte at 20 ml/kg/h for 2 hours. Outcome measures of the study were pH and changes in electrolytes, including serum potassium, sodium, chloride and bicarbonate levels at 0, 60, and 120 minutes in venous blood gas samples.</p><p>Results: Ninety patients participated in the study and were randomized to NS (30 patients), lactated Ringer's (30 patients) and Plasmalyte (30 patients) groups. Mean age was 48&#177;20 years and 50% (n=45) of the patients were female. All pH values were in the physiological range (7.35-7.45) throughout the study period. In the NS group there was a significant tendency to lower pH values, with pH values of 7.40, 7.37, and 7.36 at 0, 1, and 2 hours respectively. Average bicarbonate levels fell in the NS group (23.1, 22.2, and 21.5 mM/L) and increased in the Plasmalyte group (23.4, 23.9, and 24.4 mM/L) at 0, 1, and 2 hours, respectively. There were no significant changes in potassium, sodium, or chloride levels.</p><p>Conclusions: NS, lactated Ringer's, and Plasmalyte have no significant effect on acid-base status and all can be used safely to treat dehydrated patients in the emergency department. However, NS can effect acidosis which might be significant in patients who have underlying metabolic disturbances; thus, its use should be weighed before fluid administration in the ED.</p> ]]></description>  
<dc:creator>Hakan Hasman, Orhan Cinar, Ahmet Uzun, Erdem Cevik, Loni Jay, Bilgin Comert</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>9</prism:volume> 
  <prism:number>1</prism:number> 
  <prism:startingPage>59</prism:startingPage> 
  <prism:endingPage>64</prism:endingPage> 
  <prism:publicationDate>2011-11-23</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.medsci.org/v09p0051.htm</link> 
<title>The GHS-R Blocker D-[Lys3] GHRP-6 Serves as CCR5 Chemokine Receptor Antagonist</title> 
<guid isPermaLink="true">http://www.medsci.org/v09p0051.htm</guid> 
<description><![CDATA[ <p>[D-Lys3]-Growth Hormone Releasing Peptide-6 (DLS) is widely utilized <i>in vivo</i> and <i>in vitro</i> as a selective ghrelin receptor (GHS-R) antagonist. This antagonist is one of the most common antagonists utilized in vivo to block GHS-R function and activity. Here, we found that DLS also has the ability to modestly block chemokine function and ligand binding to the chemokine receptor CCR5. The DLS effects on RANTES binding and Erk signaling as well as calcium mobilization appears to be much stronger than its effects on MIP-1&#945; and MIP-1&#946;. CCR5 have been shown to act as major co-receptor for HIV-1 entry into the CD4 positive host cells. To this end, we also found that DLS blocks M-tropic HIV-1 propagation in activated human PBMCs. These data demonstrate that DLS may not be a highly selective GHS-R1a inhibitor and may also effects on other G-protein coupled receptor (GPCR) family members. Moreover, DLS may have some potential clinical applications in blocking HIV infectivity and CCR5-mediated migration and function in various inflammatory disease states.</p> ]]></description>  
<dc:creator>Kalpesh Patel, Vishwa Deep Dixit, Jun Ho Lee, Jie Wan Kim, Eric M. Schaffer, Dzung Nguyen, Dennis D. Taub</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>9</prism:volume> 
  <prism:number>1</prism:number> 
  <prism:startingPage>51</prism:startingPage> 
  <prism:endingPage>58</prism:endingPage> 
  <prism:publicationDate>2011-11-18</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.medsci.org/v09p0047.htm</link> 
<title>Oral Infection by Staphylococcus Aureus in Patients Affected by White Sponge Nevus: A Description of Two Cases Occurred in the Same Family</title> 
<guid isPermaLink="true">http://www.medsci.org/v09p0047.htm</guid> 
<description><![CDATA[ <p><i>Introduction.</i> White Sponge Nevus (WSN) is a rare pathology with a pathogenesis on genetic basis, a benign course and a localization affecting the mucosal keratin.</p><p>WSN is usually a symptomless pathology: when pain is present, some authors reported reduction of symptoms by taking penicillin or oral tetracycline rinses, suggesting that a bacterial overinfection could be at the base of possible painful symptoms.</p><p><i>Case Report.</i> We describe 2 patients affected by WSN, father and son: they presented two different oral diseases associated with an infection by <i>Staphylococcus aureus.</i> So, we have performed a careful oral hygiene to reduce infection in the oral cavity. In the following days we prescribed 2 rinses a day with a mouthwash containing chlorhexidine digluconate at two different percentages.</p><p><i>Discussion.</i> Early diagnosis of this lesion is important, because it allows us to exclude other more serious diseases. In the most part of cases, WSN requires no treatment because of its benign and asymptomatic behaviour: up to now, no protocol of treatment for this condition was standardized. Even if WSN is a painless condition, sometime a correlated painful symptomatology was reported.</p><p><i>Conclusions.</i> In our experience, we have achieved excellent results even with chlorhexidine digluconate rinses, considering that our treated cases were both infected by <i>Staphylococcus aureus</i>.</p><p>We hypothesize that the corrugated plaques and the altered texture of the mucosa create the right conditions for the colonization and the development of microbial species such as saprophytic bacteria or fungal species.</p> ]]></description>  
<dc:creator>Massimo Marrelli, Marco Tatullo, Gianna Dipalma, Francesco Inchingolo</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>9</prism:volume> 
  <prism:number>1</prism:number> 
  <prism:startingPage>47</prism:startingPage> 
  <prism:endingPage>50</prism:endingPage> 
  <prism:publicationDate>2011-11-18</prism:publicationDate> 
<prism:section>Case Report</prism:section>
</item>

<item>
<link>http://www.medsci.org/v09p0040.htm</link> 
<title>The Simplified Edinburgh Postnatal Depression Scale (EPDS) for Antenatal Depression: Is It a Valid Measure for Pre-Screening?</title> 
<guid isPermaLink="true">http://www.medsci.org/v09p0040.htm</guid> 
<description><![CDATA[ <p>The identification of antenatal depression is critical but poorly conducted. The aim of this study was to construct a simplified depression survey scale and to verify its efficacy as a pre-screening for antenatal depression. A total of 494 pregnant women in the third trimester of gestation who had received antenatal care at Seoul St. Mary's Hospital from July 2009 to June 2010 were included. The Edinburgh Postnatal Depression Scale (EPDS) questionnaire was completed by them. The subjects were randomly divided into two groups: 250 of training set and 244 of validation set. We designed a simplified questionnaire comprising two items of EPDS using the training set. We then validated its efficacy with the training set and reaffirmed the results with the validation set. The sum of item 5 (scare or panic) and item 8 (sadness or misery) explained 75.5% of the total score of the EPDS (AUC = 0.947). Using a score of 3 as a cut-off value of the simplified scale, sensitivity was 92.4% and specificity was 86.3%. The positive and negative predictive values were 56.2% and 98.4%, retrospectively. This study suggests that the simplified EPDS can be an efficient instrument to rule out depression during pregnancy.</p> ]]></description>  
<dc:creator>Sea Kyung Choi, Jung Jin Kim, Yong Gyu Park, Hyun Sun Ko, In Yang Park, Jong Chul Shin</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>9</prism:volume> 
  <prism:number>1</prism:number> 
  <prism:startingPage>40</prism:startingPage> 
  <prism:endingPage>46</prism:endingPage> 
  <prism:publicationDate>2011-11-17</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.medsci.org/v09p0033.htm</link> 
<title>Adverse Event Profiles of 5-Fluorouracil and Capecitabine: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS, and Reproducibility of Clinical Observations</title> 
<guid isPermaLink="true">http://www.medsci.org/v09p0033.htm</guid> 
<description><![CDATA[ <p><b>Objective:</b> The safety profiles of oral fluoropyrimidines were compared with 5-fluorouracil (5-FU) using adverse event reports (AERs) submitted to the Adverse Event Reporting System, AERS, of the US Food and Drug Administration (FDA).</p><p><b>Methods:</b> After a revision of arbitrary drug names and the deletion of duplicated submissions, AERs involving 5-FU and oral fluoropyrimidines were analyzed. Standardized official pharmacovigilance tools were used for the quantitative detection of signals, i.e., drug-associated adverse events, including the proportional reporting ratio, the reporting odds ratio, the information component given by a Bayesian confidence propagation neural network, and the empirical Bayes geometric mean.</p><p><b>Results:</b> Based on 22,017,956 co-occurrences, i.e., drug-adverse event pairs, found in 1,644,220 AERs from 2004 to 2009, it was suggested that leukopenia, neutropenia, and thrombocytopenia were more frequently accompanied by the use of 5-FU than capecitabine, whereas diarrhea, nausea, vomiting, and hand-foot syndrome were more frequently associated with capecitabine. The total number of co-occurrences was not large enough to compare tegafur, tegafur-uracil (UFT), tegafur-gimeracil-oteracil potassium (S-1), or doxifluridine to 5-FU.</p><p><b>Conclusion:</b> The results obtained herein were consistent with clinical observations, suggesting the usefulness of the FDA's AERS database and data mining methods used, but the number of co-occurrences is an important factor in signal detection.</p> ]]></description>  
<dc:creator>Kaori Kadoyama, Ikuya Miki, Takao Tamura, JB Brown, Toshiyuki Sakaeda, Yasushi Okuno</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>9</prism:volume> 
  <prism:number>1</prism:number> 
  <prism:startingPage>33</prism:startingPage> 
  <prism:endingPage>39</prism:endingPage> 
  <prism:publicationDate>2011-11-17</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.medsci.org/v09p0027.htm</link> 
<title>Efficacy of Lamivudine or Entecavir on Acute Exacerbation of Chronic Hepatitis B</title> 
<guid isPermaLink="true">http://www.medsci.org/v09p0027.htm</guid> 
<description><![CDATA[ <p><b>Background/Aims: </b>Spontaneous acute exacerbation of chronic hepatitis B virus (HBV) infection occasionally occurs in its natural history, sometimes leading rapidly to fatal hepatic failure. We compared the effects of lamivudine (LAM) with those of entecavir (ETV) treatments in acute exacerbation of chronic hepatitis B with 500 IU/L or higher alanine aminotransferase (ALT) levels.</p><p><b>Methods: </b>Thirty-four patients with acute exacerbation were consecutively treated with LAM /ETV. Their clinical improvements were compared.</p><p><b>Results: </b>Among LAM-treated and ETV-treated patients, none showed a reduction of &#60;1 log IU/mL in HBV DNA after 1 or 3 months of treatment. Initial virological response, defined as a reduction of 4 log IU/mL in HBV DNA at 6 months, with LAM and ETV, respectively, was 83.3% and 100%. One LAM patient developed hepatic encephalopathy, but all patients in both groups survived. Twelve months after treatment, 41.6% of 24 LAM group patients switched to another drug or added adefovir to their treatment due to the emergence of LAM-resistant mutants. On the other hand, patients receiving ETV did not need to change drugs.</p><p><b>Conclusions: </b>ETV appears to be as effective as LAM in the treatment of patients with acute exacerbation of chronic hepatitis B. Clinicians should carefully start to treat these patients as soon as possible.</p> ]]></description>  
<dc:creator>Tatsuo Kanda, Masami Shinozaki, Hidehiro Kamezaki, Shuang Wu, Shingo Nakamoto, Makoto Arai, Keiichi Fujiwara, Nobuaki Goto, Fumio Imazeki, Osamu Yokosuka</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>9</prism:volume> 
  <prism:number>1</prism:number> 
  <prism:startingPage>27</prism:startingPage> 
  <prism:endingPage>32</prism:endingPage> 
  <prism:publicationDate>2011-11-10</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.medsci.org/v09p0020.htm</link> 
<title>Cystic Lesions of the Jaws - A Clinicopathological Study of 322 Cases and Review of the Literature</title> 
<guid isPermaLink="true">http://www.medsci.org/v09p0020.htm</guid> 
<description><![CDATA[ <p>Three hundred and twenty-two patients (192 male and 130 female) with cystic lesions of the jaw were successfully diagnosed and treated. One hundred and fifty-five (48%) were radicular cysts, 80 (25%) were dentigerous cysts, 23 (7%) were odontogenic keratocyst (=keratocystic odontogenic tumor), 19 (6%) were eruption cysts, 16 (5%) were traumatic bone cysts, and 29 (9%) were non-odontogenic cysts.</p><p>There were 95 in the pediatric age group (1 month to 16 years) and 227 in the adult age group (17 years and older). Male to female ratio was 1 in the pediatric age group and 1.7 in the adult age group. The treatment modalities were: marsupialization, enucleation, enucleation with bone grafting, or resection. The distribution and characteristics of jaw cysts in children are different from those in adults. In children there is a relatively high rate of developmental cysts, whereas in adults the inflammatory cysts are more common. Following enucleation of a cystic jaw lesion, the entire surgical specimen and not only a biopsy specimen, should be examined histopathologically to prevent any possibility of an intramural squamous cell carcinoma that may be overlooked. The differences in prevalence of each type of jaw cyst during a lifetime may point toward a multifactorial polygenic pattern rather than a monogenic pattern.</p> ]]></description>  
<dc:creator>Esther Manor, Leonid Kachko, Max B. Puterman, George Szabo, Lipa Bodner</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>9</prism:volume> 
  <prism:number>1</prism:number> 
  <prism:startingPage>20</prism:startingPage> 
  <prism:endingPage>26</prism:endingPage> 
  <prism:publicationDate>2011-11-9</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.medsci.org/v09p0014.htm</link> 
<title>Comparison of Laparoscopic and Laparotomic Surgery for the Treatment of Peritoneal Inclusion Cyst</title> 
<guid isPermaLink="true">http://www.medsci.org/v09p0014.htm</guid> 
<description><![CDATA[ <p><b>Objectives:</b> Peritoneal inclusion cyst (PIC) is defined as a fluid-filled mesothelial-lined cysts of the pelvis and it is most frequently encountered in women of reproductive age. The treatment options are observation, hormonal management, imaging-guided aspiration, image-guided sclerotherapy and surgical excision. The objective of this study is to compare between the laparoscopic and laparotomic surgery for the treatment of PIC.</p><p><b>Methods</b>: Thirty-five patients with laparoscopy and forty-eight patients with laparotomy were included in the study. We compared the perioperative and postoperative data, the complications and the recurrence between the two groups.</p><p><b>Results</b>: There was a significantly reduced mean length of the hospital stay, estimated blood loss and complication rate in the laparoscopic group as compared to that of the laparotomic group (<i>P</i>=0.037, <i>P</i>=0.047 and <i>P</i>=0.037 respectively). There was also no statistical difference of recurrence rate between thelaparoscopic and laparotomic groups on the Cox proportional hazards model (p=0.209).</p><p><b>Conclusion</b>: Our study showed that laparoscopy was superior to the laparotomy for the mean estimated blood loss, the mean length of the hospital stay and the complication rate except for the recurrence rate.</p> ]]></description>  
<dc:creator>Suk Woo Lee, Sung Jong Lee, Dong Gyu Jang, Joo Hee Yoon, Jang Heub Kim</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>9</prism:volume> 
  <prism:number>1</prism:number> 
  <prism:startingPage>14</prism:startingPage> 
  <prism:endingPage>19</prism:endingPage> 
  <prism:publicationDate>2011-11-8</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.medsci.org/v09p0011.htm</link> 
<title>Traumatic Hemorrhage within a Cerebellar Dermoid Cyst</title> 
<guid isPermaLink="true">http://www.medsci.org/v09p0011.htm</guid> 
<description><![CDATA[ <p>Intracranial dermoid cysts with hemorrhage are fairly rare. Herein, we reported a 28-year-old female patient with a cerebellar dermoid cyst, which was found accidently on neuro-imaging after head trauma. MR scanning revealed that the lesion was located within the cerebellar vermis and was measured 3.5cm&#215;3.9cm&#215;3.0cm, with hyper-intensity on T1WI and hypo-intensity on T2WI. However, on CT imaging, it showed hyper-dense signals. It was removed completely via midline sub-occipital approach under surgical microscope. Histological examination proved it was a dermoid cyst with internal hemorrhage. In combination with literature review, we discussed the factors that might be responsible for the hemorrhage within dermoid cysts.</p> ]]></description>  
<dc:creator>Yongxin Luan, Haifeng Wang, Yanping Zhong, Xinchao Bian, Yinan Luo, Pengfei Ge</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>9</prism:volume> 
  <prism:number>1</prism:number> 
  <prism:startingPage>11</prism:startingPage> 
  <prism:endingPage>13</prism:endingPage> 
  <prism:publicationDate>2011-11-5</prism:publicationDate> 
<prism:section>Case Report</prism:section>
</item>

<item>
<link>http://www.medsci.org/v09p0001.htm</link> 
<title>Improved Synthesis Strategy for Peptide Nucleic Acids (PNA) appropriate for Cell-specific Fluorescence Imaging</title> 
<guid isPermaLink="true">http://www.medsci.org/v09p0001.htm</guid> 
<description><![CDATA[ <p>Progress in genomics and proteomics attended to the door for better understanding the recent rapid expanding complex research field of metabolomics. This trend in biomedical research increasingly focuses to the development of patient-specific therapeutic approaches with higher efficiency and sustainability. Simultaneously undesired adverse reactions are avoided. In parallel, the development of molecules for molecular imaging is required not only for the imaging of morphological structures but also for the imaging of metabolic processes like the aberrant expression of the cysteine protease cathepsin B (<i>CtsB</i>) gene and the activity of the resulting product associated with metastasis and invasiveness of malign tumors. Finally the objective is to merge imaging and therapy at the same level. The design of molecules which fulfil these responsibilities is pivotal and requires proper chemical methodologies. In this context our modified solid phase peptide chemistry using temperature shifts during synthesis is considered as an appropriate technology. We generated highly variable conjugates which consist of molecules useful as diagnostically and therapeutically active molecules. As an example the modular PNA products with the complementary sequence to the CtsB mRNA and additionally with a cathepsin B cleavage site had been prepared as functional modules for distinction of cell lines with different <i>CtsB</i> gene expression. After ligation to the modular peptide-based BioShuttle carrier, which was utilized to facilitate the delivery of the functional modules into the cells' cytoplasm, the modules were scrutinized.</p> ]]></description>  
<dc:creator>R&#252;diger Pipkorn, Manfred Wiessler, Waldemar Waldeck, Ute Hennrich, Kiyoshi Nokihara, Marcel Beining, Klaus Braun</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>9</prism:volume> 
  <prism:number>1</prism:number> 
  <prism:startingPage>1</prism:startingPage> 
  <prism:endingPage>10</prism:endingPage> 
  <prism:publicationDate>2011-11-5</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<atom:link href="http://www.medsci.org/rss/current.xml" rel="self" type="application/rss+xml" />
  </channel>
</rss>

